Brian M. Silver - 27 Dec 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Signature
/s/ Brian M. Silver
Issuer symbol
TCRX
Transactions as of
27 Dec 2022
Net transactions value
+$9,217
Form type
4
Filing time
29 Dec 2022, 13:34:48 UTC
Previous filing
27 Jul 2022
Next filing
15 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRX Voting Common Stock Purchase $4,276 +2,842 +11% $1.50 29,727 27 Dec 2022 Direct F1
transaction TCRX Voting Common Stock Purchase $4,941 +3,158 +11% $1.56 32,885 28 Dec 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $1.46 to $1.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $1.55 to $1.57, inclusive.